BLBenjamin L. EbertMay 12, 2026New paperautoPaperIkaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesBlood · 2026 · Lucia Y Chen, Adolfo Aleman, Marta Larrayoz et al.
